Potentially Inappropriate Medication Use Among Older Patients with Diabetes in a Chinese Community
Experimental and Clinical Endocrinology & Diabetes · 01.10.2023 · 131 (10) · 548-553
DOI: 10.1055/a-2123-0734 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental and Clinical Endocrinology & Diabetes, erschienen am 01.10.2023. Verfasst von Xingxing Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Second Outpatient Department, Peking University Third Hospital, Beijing China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Potentially Inappropriate Medication List. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Potentially inappropriate medications (PIMs) are frequently prescribed to older people with diabetes. This study aimed to assess the prevalence of PIM use in older people with diabetes and identify potential risk factors influencing the development of PIM use.
Methods
This was a cross-sectional study conducted in an outpatient setting in Beijing, China, using Chinese criteria. The prevalence of PIM use, polypharmacy, and comorbidities in older adults with diabetes in an outpatient setting was measured. Logistic models were employed to investigate the association among polypharmacy, comorbidities, and PIM use.
Results
The prevalence of PIM use and polypharmacy was 50.1% and 70.8%, respectively. The most common comorbidities were hypertension (68.0%), hyperlipemia (56.6%), and stroke (36.3%), and the top three inappropriately used medications were insulin (22.0%), clopidogrel (11.9%), and eszopiclone (9.81%). Age (OR 1.025; 95% CI 1.009, 1.042), the number of diagnoses (OR 1.172; 95% CI 1.114, 1.232), coronary heart disease (OR 1.557; 95% CI 1.207, 2.009), and polypharmacy (OR 1.697; 95% CI 1.252, 2.301) were associated with PIM use.
Conclusions
Given the higher rate of PIM use among older adults with diabetes, strategies and interventions targeting this population are needed to minimize PIM use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- The Second Outpatient Department, Peking University Third Hospital, Beijing China.
- Department of Pharmacy, Peking University Third Hospital, Beijing, China.
- Department of Endocrinology and Metabolism, Peking University Third Hospital, Beijing, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhao, X., Li, L., Guo, X., Wang, J., Yan, Y., & Le, Y. (2023). Potentially Inappropriate Medication Use Among Older Patients with Diabetes in a Chinese Community. Experimental and Clinical Endocrinology & Diabetes, 131(10), 548-553. https://doi.org/10.1055/a-2123-0734
Vancouver
Zhao X, Li L, Guo X, Wang J, Yan Y, Le Y. Potentially Inappropriate Medication Use Among Older Patients with Diabetes in a Chinese Community. Experimental and Clinical Endocrinology & Diabetes. 2023;131(10):548-553. doi:10.1055/a-2123-0734
BibTeX
@article{Zhao2023,
author = {Zhao, Xingxing and Li, Lei and Guo, Xiujun and Wang, Jianqiang and Yan, Yingying and Le, Yunyi},
title = {Potentially Inappropriate Medication Use Among Older Patients with Diabetes in a Chinese Community},
journal = {Experimental and Clinical Endocrinology & Diabetes},
year = {2023},
volume = {131},
number = {10},
pages = {548--553},
doi = {10.1055/a-2123-0734}
}
EUVIMED